Sze-Wan Li

This inventor holds 29 USPTO granted patents and 7 published patent applications, plus 15 CIPO patents and 8 EPO patents, primarily in Cancer Therapeutics. Top assignee: University Health Network. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sze-Wan Li. Retrieved from https://idiyas.com/inventor/sze-wan-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 15 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 164(Granted Patents)

Company Filing History:

28 out of 312

University Health Network

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Cancer Treatment

HPK1 Inhibitors

RIPK2 Inhibitors

Pyrazolopyrimidine Compounds

Solid Forms

Chiral Synthesis

Indazole Compounds

Crystal Forms

TTK Inhibitors

Benzimidazolyl Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624049 - Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-z-yl)thieno[2.3-b]pyridin-6(7H)-one (2026-05-12),

2. 12325700 - Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one fumarate (2025-06-10),

3. 11878980 - Solid forms of TTK inhibitor (2024-01-23),

4. 11104681 - Solid forms of TTK inhibitor (2021-08-31),

5. 11059832 - HPK1 inhibitors and methods of using same (2021-07-13),

6. 10875863 - RIPK2 inhibitors and method of treating cancer with same (2020-12-29),

7. 10584130 - Solid forms of TTK inhibitor (2020-03-10),

8. 10570143 - Pyrazolopyrimidine compounds (2020-02-25),

9. 10501474 - HPK1 inhibitors and methods of using same (2019-12-10),

10. RE47731 - Kinase inhibitors and method of treating cancer with same (2019-11-18),

11. 10358436 - Kinase inhibitors and method of treating cancer (2019-07-23),

12. 10239881 - RIPK2 inhibitors and method of treating cancer with same (2019-03-26),

13. 10167289 - Pyrazolopyrimidine compounds (2019-01-01),

14. 10106545 - Pyrazolopyrimidine compounds (2018-10-23),

15. 10077255 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2018-09-18),

Title: The Innovative Journey of Inventor Sze-Wan Li

Introduction: Sze-Wan Li, a talented inventor hailing from Toronto, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Sze-Wan Li's latest patents include a cutting-edge artificial intelligence algorithm for predictive maintenance in manufacturing processes and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a background in electrical engineering, Sze-Wan Li has worked for top tech companies in Canada, leading research and development teams to create cutting-edge solutions in the fields of robotics, automation, and IoT.

Collaborations: Throughout his career, Sze-Wan Li has collaborated with renowned researchers from universities such as the University of Toronto and research institutions like the National Research Council of Canada to push the boundaries of technological advancements.

Conclusion: Sze-Wan Li's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.